Allergic bronchopulmonary aspergillosis occurs in patients with bronchial asthma or cystic fibrosis. This case series explores its clinical presentation and diagnostic challenges.

A randomized controlled trial evaluates the safety of furosemide in preterm infants at risk of bronchopulmonary dysplasia. Findings from the study will be presented during the Pediatric Academic ...

US-based biotechnology company Airway Therapeutics is to launch a multinational Phase III clinical trial of zelpultide alfa, a drug designed to prevent bronchopulmonary dysplasia (BPD) in preterm ...

An artificial neural network demonstrated high accuracy in detecting bronchopulmonary dysplasia in infants using air flow data, according to a presentation at the European Respiratory Society ...

Allergic bronchopulmonary aspergillosis (ABPA), if not diagnosed and treated early, can cause life-threatening complications. Current immunodiagnostic methods have been complicated by poorly ...